TG THERAPEUTICS, INC. (TGTX) earnings date

Nasdaq · Mid cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 36 days, typically, give or take 11 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Mon, Nov 9, 2026before open 40 8-K
Q2 FY2026Mon, Aug 3, 2026before open 34 8-K
Q1 FY2026Wed, May 6, 2026before open 36 8-K
Q4 FY2025Thu, Feb 26, 2026before open 57 8-K
Q3 FY2025Mon, Nov 3, 2025before open 34 8-K
Q2 FY2025Mon, Aug 4, 2025before open 35 8-K
Q1 FY2025Mon, May 5, 2025before open 35 8-K
Q4 FY2024Mon, Mar 3, 2025before open 62 8-K

What they guided beta

Q3 FY2026 "Document Exhibit 99.1 TG Therapeutics Reports Third Quarter 2026 Financial Results and Raises Full-Year Revenue Guidance Raises full-year 2026 total global revenue guidance to approximately $1 billion, from approximately $950 million Raises full-year 2026 BRIUMVI U.S. net product revenue guidance to approximately $915–920 million, from $890–905 million Third-quarter 2026 total global revenue of approximately $260 million, including approximately $233 million in BRIUMVI U.S. net product revenue MSToronto2026 presentations highlight seven-year BRIUMVI efficacy and safety follow-up, positive ENHA" exhibit
Q3 FY2026 "Weiss, Chairman and Chief Executive Officer of TG Therapeutics, stated, “With solid third-quarter performance and a strong fourth quarter anticipated, we are on track to exceed $1 billion in global revenue in 2026, less than four years after launching BRIUMVI." exhibit
Q3 FY2026 "Weiss continued, “Looking ahead, we see a series of important catalysts over the next 18 to 24 months, including pivotal Phase 3 subcutaneous BRIUMVI results expected around year-end or early 2027, a potential launch of simplified IV initiation in mid-2027, additional clinical data from our expanding pipeline, and a potential subcutaneous BRIUMVI launch in 2028." exhibit
Q3 FY2026 "Our increased full-year revenue guidance reflects the continued strength of our commercial business, while the approximately $100 million of shares repurchased during the quarter underscores our confidence in TG's long-term value.”" exhibit
Q3 FY2026 "Top-line Phase 3 data are expected by year-end 2026 or early 2027." exhibit
Q2 FY2026 "TG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI ® Revenue Guidance" exhibit
Q2 FY2026 "Raises full year 2026 total global revenue target to approximately $950 million and raises full year 2026 BRIUMVI U.S. net product revenue target to approximately $890 - 905 million" exhibit
Q2 FY2026 "New York, NY, (August 3, 2026 ) – TG Therapeutics, Inc. (NASDAQ: TGTX) (the Company or TG Therapeutics) today announced its financial results for the second quarter of 2026, along with recent company developments and provided an update on 2026 financial guidance." exhibit
Q2 FY2026 "BRIUMVI delivered another outstanding commercial quarter, exceeding our expectations once again and putting us on track to exit 2026 at an approximately $1 billion annualized U.S. BRIUMVI revenue run rate." exhibit
Q2 FY2026 "Top-line Phase 3 data is expected year-end 2026 or early 2027" exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/TGTX
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/TGTX

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

TGTX earnings date badge

HTML

<a href="https://veritasdata.dev/company/TGTX/"><img src="https://veritasdata.dev/embed/TGTX.svg" alt="TGTX earnings date" width="240" height="56"></a>

Markdown

[![TGTX earnings date](https://veritasdata.dev/embed/TGTX.svg)](https://veritasdata.dev/company/TGTX/)

Script

<script async src="https://veritasdata.dev/embed/TGTX.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/TGTX"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.